Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 2.   IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity
  2. Shirota, Hidekazu; Klinman, Dennis; Ito, Shuku-ei; Ito, Hiroyasu; Kubo, Masato; Ishioka, Chikashi
  3. CANCER IMMUNOLOGY RESEARCH. 2017, Jan; 5(1): 61-71.
  1. 3.   The split personality of NKT cells in malignancy, autoimmune and allergic disorders
  2. Subleski, J. J.; Jiang, Q.; Weiss, J. M.; Wiltrout, R. H.
  3. Immunotherapy. 2011, Oct; 3(10): 1167-1184.
  1. 4.   The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4(+) NKT cells
  2. Wang, L.; Carr, T.; Xiong, Y. M.; Wildt, K. F.; Zhu, J. F.; Feigenbaum, L.; Bendelac, A.; Bosselut, R.
  3. European Journal of Immunology. 2010, Sep; 40(9): 2385-2390.
  1. 5.   Application of tissue-specific NK and NKT cell activity for tumor immunotherapy
  2. Subleski, J. J.; Wiltrout, R. H.; Weiss, J. M.
  3. Journal of Autoimmunity. 2009, Nov-Dec; 33(3-4): 275-281.
  1. 6.   A Central Role for Transcription Factor C/EBP-beta in Regulating CD1d Gene Expression in Human Keratinocytes
  2. Sikder, H.; Zhao, Y.; Balato, A.; Chapoval, A.; Fishelevich, R.; Gade, P.; Singh, I. S.; Kalvakolanu, D. V.; Johnson, P. F.; Gaspari, A. A.
  3. Journal of Immunology. 2009 183(3): 1657-1666.
  1. 7.   NKT cells: to suppress or not to suppress, that is the question
  2. Subleski, J. J.; Ortaldo, J. R.
  3. Journal of Leukocyte Biology. 2009 86(4): 751-752.
  1. 8.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 9.   A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
  2. Lueders, K. K.; De Rosa, S. C.; Valentin, A.; Pavlakis, G. N.; Roederer, M.; Hamer, D. H.
  3. Aids Research and Human Retroviruses. 2004 20(2): 145-150.
  1. 10.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 11.   Natural killer cells are persistently infected and resistant to direct killing by HIV-1
  2. Valentin, A.; Pavlakis, G. N.
  3. Anticancer Research. 2003 23(3A): 2071-2075.
  1. 12.   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
  2. Smyth, M. J.; Cretney, E.; Takeda, K.; Wiltrout, R. H.; Sedger, L. M.; Kayagaki, N.; Yagita, H.; Okumura, K.
  3. Journal of Experimental Medicine. 2001 193(6): 661-670.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel